Berkshire Partners and TPG Growth’s $275 million investment in Precision Medicine Group

Debevoise & Plimpton LLP successfully advised Precision Medicine Group on a new $275 million investment, led by Berkshire Partners and TPG Growth Precision Medicine Group (PMG)…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here